» Articles » PMID: 27632232

Changes in Male Circumcision Prevalence and Risk Compensation in the Kisumu, Kenya Population, 2008-2013

Overview
Date 2016 Sep 16
PMID 27632232
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Three randomized controlled trials showed that voluntary medical male circumcision (VMMC) reduces the risk of female-to-male HIV transmission by approximately 60%. However, data from communities where VMMC programs have been implemented are needed to assess changes in circumcision prevalence and whether men and women compensate for perceived reductions in risk by increasing their HIV risk behaviors.

Methods: Scale-up of free VMMC began in Kisumu, Kenya in 2008. Between 2009 and 2013, a sequence of 3 unlinked cross-sectional surveys were conducted. All individuals 15-49 years of age residing in randomly selected households were interviewed and offered HIV testing. Male circumcision status was confirmed by examination. Design-adjusted bivariate comparisons and multivariable analyses were used for statistical inference.

Results: The prevalence of male circumcision increased from 32% (95% CI: 26% to 38%) in 2009 to 60% (95% CI: 56% to 63%) in 2013. The adjusted prevalence ratio of HIV and genital ulcer disease in circumcised compared with uncircumcised men was 0.48 (95% CI: 0.36 to 0.66) and 0.51 (95% CI: 0.37 to 0.69), respectively. There was no association between circumcision status and sexual behaviors, HIV knowledge, or indicators of risk perception.

Conclusions: The conditions necessary for the VMMC program to have a significant public health impact are present in Kisumu, Kenya. Between 2009 and 2013, circumcision prevalence increased from 30% to 60%; HIV prevalence in circumcised men was half that of uncircumcised men, and there was no or minimal sexual risk compensation.

Citing Articles

Estimates of the prevalence of male circumcision in sub-Saharan Africa from 2010-2023-A systematic review and meta-analysis.

Elsayed B, Elmarasi M, Madzime R, Mapahla L, ElBadway M, Chivese T PLoS One. 2024; 19(3):e0298387.

PMID: 38478528 PMC: 10936832. DOI: 10.1371/journal.pone.0298387.


Understanding the Evolving Role of Voluntary Medical Male Circumcision as a Public Health Strategy in Eastern and Southern Africa: Opportunities and Challenges.

Bershteyn A, Mudimu E, Platais I, Mwalili S, Zulu J, Mwanza W Curr HIV/AIDS Rep. 2022; 19(6):526-536.

PMID: 36459306 PMC: 9759505. DOI: 10.1007/s11904-022-00639-5.


Association between medical male circumcision and HIV risk compensation among heterosexual men: a systematic review and meta-analysis.

Gao Y, Yuan T, Zhan Y, Qian H, Sun Y, Zheng W Lancet Glob Health. 2021; 9(7):e932-e941.

PMID: 33939956 PMC: 8690595. DOI: 10.1016/S2214-109X(21)00102-9.


Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study.

Peebles K, Mittler J, Goodreau S, Murphy J, Reid M, Abernethy N Sci Rep. 2021; 11(1):6798.

PMID: 33762616 PMC: 7991033. DOI: 10.1038/s41598-021-85487-w.


Sexual risk compensation following voluntary medical male circumcision: Results from a prospective cohort study amongst human immunodeficiency virus-negative adult men in Botswana.

Spees L, Wirth K, Mawandia S, Bazghina-Werq S, Ledikwe J South Afr J HIV Med. 2021; 21(1):1157.

PMID: 33391832 PMC: 7756904. DOI: 10.4102/sajhivmed.v21i1.1157.


References
1.
Mehta S, Moses S, Agot K, Maclean I, Odoyo-June E, Li H . Medical male circumcision and herpes simplex virus 2 acquisition: posttrial surveillance in Kisumu, Kenya. J Infect Dis. 2013; 208(11):1869-76. PMC: 3814838. DOI: 10.1093/infdis/jit371. View

2.
Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J . Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013; 10(9):e1001509. PMC: 3760784. DOI: 10.1371/journal.pmed.1001509. View

3.
Westercamp N, Agot K, Jaoko W, Bailey R . Risk compensation following male circumcision: results from a two-year prospective cohort study of recently circumcised and uncircumcised men in Nyanza Province, Kenya. AIDS Behav. 2014; 18(9):1764-75. DOI: 10.1007/s10461-014-0846-4. View

4.
Lissouba P, Taljaard D, Rech D, Dermaux-Msimang V, Legeai C, Lewis D . Adult male circumcision as an intervention against HIV: an operational study of uptake in a South African community (ANRS 12126). BMC Infect Dis. 2011; 11:253. PMC: 3192707. DOI: 10.1186/1471-2334-11-253. View

5.
Cassell M, Halperin D, Shelton J, Stanton D . Risk compensation: the Achilles' heel of innovations in HIV prevention?. BMJ. 2006; 332(7541):605-7. PMC: 1397752. DOI: 10.1136/bmj.332.7541.605. View